Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Endocrinol.

Sec. Pituitary Endocrinology

Volume 16 - 2025 | doi: 10.3389/fendo.2025.1587462

Correction: Circulating miR-28-5p is overexpressed in patients with sarcopenia despite longterm remission of Cushing's syndrome: a pilot study

Provisionally accepted
Marta Seco-CerveraMarta Seco-Cervera1José Santiago Ibáñez CabellosJosé Santiago Ibáñez Cabellos2Federico V PallardóFederico V Pallardó1Jose Luis García-GiménezJose Luis García-Giménez1Anna AulinasAnna Aulinas3,4*Luciana MartelLuciana Martel4Susan M WebbSusan M Webb3,4,5*Elena ValassiElena Valassi3*
  • 1U733, Centre for Biomedical Network Research on Rare Diseases (CIBERER-ISCIII), Madrid, Asturias, Spain
  • 2EpiDisease S.L., Valencia, Spain
  • 3CIBERER Unit 747, ISCIII, Madrid, Asturias, Spain
  • 4Sant Pau Institute for Biomedical Research, Barcelona, Catalonia, Spain
  • 5Autonomous University of Barcelona, Barcelona, Spain

This article is a correction to:

  1. Circulating miR-28-5p is overexpressed in patients with sarcopenia despite long-term remission of Cushing’s syndrome: a pilot study

    1. Read original article

The final, formatted version of the article will be published soon.

Select one of your emails

You have multiple emails registered with Frontiers:

Notify me on publication

Please enter your email address:

If you already have an account, please login

You don't have a Frontiers account ? You can register here

Incorrect Funding In the published article, there was an error in the Funding statement. [The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article ]. The correct Funding statement appears below.FUNDING"This work was supported by a grant from the Instituto de Salud Carlos III (FIS PI21/01223), European Regional Development Fund (FEDER) funds". The authors apologize for this error and state that this does not change

Keywords: microRNA, miR-28-5p, myomiRs, Sarcopenia, Myopathy, Cushing Syndrome

Received: 04 Mar 2025; Accepted: 30 May 2025.

Copyright: © 2025 Seco-Cervera, Cabellos, Pallardó, García-Giménez, Aulinas, Martel, Webb and Valassi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Anna Aulinas, CIBERER Unit 747, ISCIII, Madrid, Asturias, Spain
Susan M Webb, Autonomous University of Barcelona, Barcelona, Spain
Elena Valassi, CIBERER Unit 747, ISCIII, Madrid, Asturias, Spain

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Supplementary Material